BIO Patient and Health Advocacy Summit: Registration Now Open
August 30, 2013
The Power of Partnerships
Please join us for the BIO Patient and Health Advocacy Summit. This event will bring together voluntary health organizations and the biotechnology industry for two days of policy-driven panel discussions, best practice seminars and invaluable networking opportunities.
The Summit will take place on October 8-9, 2013 at the Renaissance Mayflower Hotel in Washington D.C. To register for this event, please visit here.
Please note that BIO has secured a room block at the Mayflower Hotel. A limited number of rooms have been set aside at the rate of $349 a night. You can register for a room at the following link: BIO Room Block.
Topics to be discussed:
- The Legislative Landscape: What to Expect in 2013 and Beyond
- One Week In: A Look at Enrollment, Coverage and Access in the New Health Insurance Exchanges
- Defining Patient-Focused Drug Development: Engaging the FDA
- Realizing Patient Focused-Drug Development: Embracing the Voice of the Patient
- Enabling Patient-Focused Drug Development: Investing in Innovation
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO is a 501(c)(6) non-profit organization headquartered in Washington, D.C. We provide advocacy, business development and communications services for more than 1,100 members worldwide. It is our mission to be the champion of biotechnology and the advocate for our member organizations – both large and small.
Our members – many of whom are small emerging companies – are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. Our members work every day to improve the human condition by curing the sick, feeding the hungry or developing cleaner, safer and healthier sources of energy.
Currently, there are more than 400 biotechnology drugs in clinical trials targeting more than 200 diseases. In agriculture, there are more than 13.3 million farmers around the world using agricultural biotech processes and biotech crops are grown on more than 2.3 billion acres of farmland worldwide. Through industrial and environmental biotechnology, we can now harness microorganisms in new and exciting ways to manufacture polymers, vitamins, enzymes or transportation fuel, which will help us move from a petroleum-based economy to a “bio-based economy.”
Sign up for updates straight to your inbox.